D-serine treatment for neurological disorders that cause seizures
US10307387B1 · kind B1 · utility
3Cited by
4References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 7, 2017 |
| Grant date | Jun 4, 2019 |
| Priority date | — |
| Expiry date | Dec 7, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
D-serine is used to treat a neurological disorder, such as epilepsy, that cases seizures. A composition comprising D-serine is artificially administered to a patient in an effective amount by selectively contacting a region of the patient's brain with the composition. The region of the brain selectively contacted with the composition has cells expressing GluN3 subunit-containing triheteromeric NMDARs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.